Global market for vaccines forecast to reach $36.3 billion by 2013
According to a new technical market research report, Vaccines Technologies and Global Markets from BCC Research (www.bccresearch.com), worldwide turnover of vaccine products will be worth $22.4 billion in 2008. This is expected to increase to $36.3 billion by 2013, with this sector seeing a compound average annual growth rate of 10.1%.
The market is broken down into applications of human and veterinary or animal vaccines. Of these, the human vaccines have the largest share of the sector. Expected to be worth $18.7 billion in 2008, this segment should reach a value of $31.3 billion by 2013, with a CAGR of 10.9%. Pediatric vaccines have been the leading human vaccine segment, traditionally, says BCC. However, it adds, adult and therapeutic vaccines are likely to usurp this position in the near future.
Large MNCs participating
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze